GESA analysis also indicated PUS1 may be involved in DNA_REPAIR, E2F_TARGETS, MYC_TARGETS_V2, G2M_CHECKPOINT, and MYC_TARGETS_V1 pathways, potentially triggering NSCLC malignancy. This evidence concerns the gene PUS1 and non-small cell lung carcinoma.